The 7th Huaining Blueberry Culture and Tourism Festival and the First Blueberry Production and Marketing Conference Held

HUAINING, China, June 15, 2024 /Xinhua-AsiaNet/– The 7th Huaining Blueberry Culture and Tourism Festival and the First Blueberry Production and Marketing Conference was held in Huaining County on June 12. Leaders of business associations, entrepreneurs, projects signing representatives, central and Anhui provincial medias attended the event. In recent years, the Huaining County Party Committee and Government have […]

HUAINING, China, June 15, 2024 /Xinhua-AsiaNet/– The 7th Huaining Blueberry Culture and Tourism Festival and the First Blueberry Production and Marketing Conference was held in Huaining County on June 12. Leaders of business associations, entrepreneurs, projects signing representatives, central and Anhui provincial medias attended the event.

In recent years, the Huaining County Party Committee and Government have attached great importance to the development of the blueberry industry, and created a “one county, one industry (blueberry)” entire industry chain. Entering Huaining, there are nearly 100,000 acres of blueberry planting base, more than 200 blueberry planting companies, and 8 deep-processing companies. It is expected that the fruit-bearing area this year will be 60,000 acres, the fresh fruit output will be 36,000 tons, and the comprehensive output value will exceed 7 billion yuan. “Huaining Blueberry” has been approved as a national geographical indication certification trademark, and has been selected into the “National Famous, Special and Excellent New Agricultural Products Catalog” and a typical case of sustainable development of global brands. It is the largest county-level blueberry planting area in the Yangtze River Delta, forming an entire industrial chain of seedling, planting, sales and processing, and new business formats and new models that integrate the three rural industries such as blueberry marathon and picking leisure.

At the opening ceremony, Yu Xuefeng, Secretary of the Huaining County Party Committee, extended a warm invitation to the leading enterprises in the blueberry industry. During the event, a blueberry industry development summit and a blueberry industry exchange meeting were held, as well as the promotion of key cultural and tourism projects, the signing of 18 projects including “the entire anthocyanin extraction industry chain project”, 3 Huaining blueberry cooperative logistics partners and 8 High-quality Development Workstations were awarded licenses.

The Huaining Blueberry Culture and Tourism Festival has been held for seven consecutive years and has become a professional festival for Huaning County to enhance cultural exchanges and promote the development of the blueberry industry. It is also an important bridge to expand opening-up and promote high-quality economic development.

Source: The Organizing Committee of the 7th Huaining Blueberry Culture and Tourism Festival

From Awareness to Action on Global Fatty Liver Day

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and […]

Global Liver Institute Unites the Field in Times of Name Changes and New Treatments

WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) — Today marks the seventh annual Global Fatty Liver Day (formerly International NASH Day), led by Global Liver Institute (GLI) with the theme “Act Now, Screen Today.” This campaign underscores the crucial need for early identification and treatment of fatty liver disease to prevent its progression to chronic liver disease, cirrhosis, or cancer.

Fatty liver disease is now estimated to affect 1 in 3 adults worldwide, and its prevalence is increasing. Fatty liver disease during childhood, once unheard of, is also on the rise. Early detection and timely intervention, whether through lifestyle changes or medical treatments, are essential in stopping and even reversing the progression of the disease. “Act Now, Screen Today” emphasizes that liver health is achievable, but action must begin immediately. Across the globe, partners are driving awareness and educational efforts and ensuring broader access to essential screenings and care.

Global Fatty Liver Day, observed annually on the second Thursday of June, is a rallying cry for collective action to address the growing prevalence of fatty liver disease, the most common liver disease worldwide. “Act Now, Screen Today” reminds everyone that liver health is within reach. Here are specific actions you can take today:

  • Take advantage of liver health screening events happening globally to get assessed for fatty liver disease or schedule a check-up with your doctor, especially if you are managing closely associated metabolic conditions like obesity or diabetes
  • Increase physical activity, as maintaining an active lifestyle can improve liver health
  • Learn about fatty liver disease and its risk factors to take proactive steps towards prevention and management yourself or learn more about the latest research and guidelines for your patients.

With a robust pipeline of pharmaceutical treatments that address diverse mechanisms of action in progress, it is important to identify individuals’ position within the progression of fatty liver disease so that they are poised to receive the most appropriate care possible. Notably, pharmaceutical treatments are available (for certain groups with advanced disease) in two countries, the United States (resmetirom) and India (saroglitazar).

“As a community, we stand at a critical time for the broader global health system to act now to support patients,” shares Donna R. Cryer, JD, Founder and CEO of GLI. “As pharmaceutical treatment options gain approval in different geographies, health payers and systems must listen to the call from global advocates and not place undue obstacles to care – whether that be required biopsy, ambiguous lifestyle requirements, or other hurdles – so that patients are able to access the care they require, no matter who or where they are.”

Recognizing the importance of early detection, a diverse range of partners, including healthcare providers, patient advocacy groups, and community organizations, have joined forces to “Act Now, Screen Today” and launch screening events around the world. From Chile to Nigeria to the Netherlands, the Philippines, and beyond, these events aim to raise awareness, provide education, and offer screening services to individuals at risk of fatty liver disease or the providers who care for them. Global Fatty Liver Day activities are driving positive change at the grassroots level.

“Global Fatty Liver Day is an urgent call-to-action to unite our global efforts to confront the scourge of fatty liver disease,” shares Cat Evans, Director of Program Operations at GLI. “We must act now. By working together, we have the power to create significant change in preventing and managing this pressing health issue through our collaborative efforts.”

Although the challenge of fatty liver disease to the well-being of communities around the globe is great, the power of locally-rooted, collective efforts can turn the tide towards positive change by heightening awareness, equipping people and their healthcare providers with prevention and management tools, expanding understanding of the disease through research, and protecting future liver health through effective policies.

About Global Liver Institute

Global Liver Institute (GLI) is a 501(c)3 nonprofit organization founded in the belief that liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. Operating globally, GLI is committed to solving the problems that matter to liver patients and equipping advocates to improve the lives of individuals and families impacted by liver disease. Follow GLI on FacebookInstagramLinkedIn, and YouTube, or visit www.globalliver.org. GLI is the host of Global Fatty Liver Day.

Christine Maalouf
Global Liver Institute
cmaalouf@globalliver.org

GlobeNewswire Distribution ID 9153607

Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

ADALVO LIMITED Anil Okay, Adalvo CEO, expresses his thoughts on this milestone SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza® pre-filled pen, indicated for the treatment of type 2 […]

ADALVO LIMITED
Anil Okay, Adalvo CEO, expresses his thoughts on this milestone

SAN ĠWANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) — Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.

As a bioequivalent version of Victoza® pre-filled pen, indicated for the treatment of type 2 diabetes, this peptide drug achieved global sales exceeding $4.8 billion in 2023, as reported by IQVIA.

The successful development of Liraglutide highlights Adalvo’s capability to offer a diverse and comprehensive diabetes portfolio, encompassing both complex peptide injectables and small molecule oral treatments.

Adalvo’s commitment to providing access to high-quality differentiated products while simultaneously navigating manufacturing complexities reinforces Adalvo’s position as a trusted leader in the pharmaceutical industry.

Click Here To View Adalvo’s Diabetes Portfolio

At Adalvo, there are no half-measures – they are always on target. Their mission is to be faster and stronger than their competitors, driving their vision forward with a winning team.

Adalvo is committed to maintaining the highest standards of excellence in all their endeavors and looks forward to continuing to deliver innovative healthcare solutions that make a difference in the lives of patients worldwide.

About Adalvo

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 130 countries and over 140 commercial partners globally. The company’s declared purpose is to make a difference for patients all over the world, driven by our smart collaboration network and commitment to delivering the highest quality differentiated products and services to our partners.

Adalvo takes pride in their ability to help partners reach their goals – be those increasing revenues or pushing into new markets. Tirelessly strives for excellence in all of its endeavours, driven by a deep-rooted passion for making a difference for partners.

The company’s purpose-driven culture is committed to improving the lives of patients around the world. Adalvo’s dynamic leadership team brings significant experience and industry know-how, which has helped to establish the company as a reliable global partner in the industry.

Contacts: Gabrielle Cassar, gabrielle.cassar@adalvo.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e1e895aa-f689-4215-a1f8-25285851af9d

GlobeNewswire Distribution ID 1000966220

Nikkiso Clean Energy & Industrial Gases Group Announces CEO Transition July 1, 2024

TEMECULA, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376), announced today after a Board vote, that effective July 1, 2024, Adrian Ridge will succeed Peter Wagner as Nikkiso Clean Energy & Industrial Gases Group’s (part of Nikkiso’s Industrial Division) as Chief Executive Officer. Wagner will stay on in a Board role […]

TEMECULA, Calif., June 13, 2024 (GLOBE NEWSWIRE) — Nikkiso Co., Ltd. (TSE: 6376), announced today after a Board vote, that effective July 1, 2024, Adrian Ridge will succeed Peter Wagner as Nikkiso Clean Energy & Industrial Gases Group’s (part of Nikkiso’s Industrial Division) as Chief Executive Officer. Wagner will stay on in a Board role as Executive Chairman for Nikkiso CE&IG Group.

As CEO, Ridge, who is currently Executive Vice President, Operations and Manufacturing for Nikkiso CE&IG Group, will drive operational and financial results and ready the Group for future growth. Wagner’s new role as Executive Chairman will focus on driving the vision and long-term strategy of the Group in an advisor capacity.

“In six years under Peter’s leadership, Nikkiso CE&IG has more than quadrupled business, and is positioned for strong continued growth,” said Toshihiko Kai, President and CEO, Nikkiso. “I want to thank him for his leadership, and welcome Adrian as the Group’s new CEO.”

Prior to joining Nikkiso in 2018, Wagner was CEO and Managing Director at LEWA Group. Ridge joined Nikkiso in 2022 after approximately 30 years at Atlas Copco serving in various leadership positions.

About Nikkiso Co. Ltd.

Since its establishment in 1953, Nikkiso has contributed to solving social issues by anticipating the changing times with world-first and Japan-first technologies and products. In the industrial business, Nikkiso has created new markets by developing products in the energy field, hemodialysis-related products in the medical business, and CFRP (carbon fiber reinforced plastic) aerostructures in the aerospace business.

About Nikkiso Clean Energy & Industrial Gases Group

The Nikkiso Clean Energy & Industrial Gases Group is a leading provider of cryogenic equipment, technologies and applications for clean energy and industrial gas market segments. The Group employs more than 1,600 people in 22 countries and is headed by Cryogenic Industries, Inc. in Southern California, U.S., which is a wholly owned subsidiary of Nikkiso Co., Ltd. (TSE: 6376).

Media contact
Lisa Adams
+1 405 492 1689

GlobeNewswire Distribution ID 9153273

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

New sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian cancer SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at improving access to homologous recombination deficiency (HRD) diagnostic testing for high-grade serous […]

New sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian cancer

SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at improving access to homologous recombination deficiency (HRD) diagnostic testing for high-grade serous ovarian cancer (HGSOC) patients. A new sponsored testing program leveraging Myriad’s MyChoice HRD Plus and MyChoice CDx Plus Tests (collectively referred to as Myriad’s MyChoice Tests) is now available in Argentina, Brazil, Chile, Colombia, Egypt, Netherlands, Saudia Arabia, Singapore, and United Arab Emirates.

HRD testing is an important predictive and prognostic biomarker for patients who have ovarian cancer. Myriad’s MyChoice Tests determine HRD status in women with ovarian cancer. Clinicians can order this test through their local pathology labs and samples are sent to Myriad Genetics.

This collaboration delivers on both companies’ shared commitment to improve care for patients with advanced ovarian cancer by facilitating access to genetic testing and demonstrates a mutual dedication to meeting an unmet need for patients who otherwise may not have access to testing.

“Our collaboration with GSK is an important step forward in providing critical genetic insights that can help clinicians guide more personalized ovarian cancer treatment decisions,” said Patrick Burke, PhD, EVP of Strategy and Innovation, Myriad Genetics. “In the pursuit of advancing healthcare equity, Myriad is committed to extending the reach of our diagnostic solutions, like Myriad’s MyChoice Tests into additional markets to support more targeted patient care based on their genomic profile.”

About Myriad’s MyChoice Test
Myriad’s MyChoice® test is the most comprehensive tumor test for determining HRD status based on the assessment of genomic alterations in genes such as BRCA1 and BRCA2 and Genomic Instability Score (GIS) status using Myriad’s proprietary algorithm.  It enables healthcare professionals to identify patients with advanced ovarian cancer who are more likely to respond to treatment with targeted therapies.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including that this collaboration will increase access to HRD testing and can help clinicians guide more personalized ovarian cancer treatment decisions for patients. These “forward-looking statements” are management’s expectations of future events as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially and adversely from those anticipated. Such factors include those risks described in the company’s filings with the U.S. Securities and Exchange Commission, including the company’s Annual Report on Form 10-K filed on February 28, 2024, as well as any updates to those risk factors filed from time to time in the company’s Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. Myriad is not under any obligation, and it expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise except as required by law.

Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com

GlobeNewswire Distribution ID 9151576

President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday

FII PRIORITY Rio Press Release Image FII Institute is honoured to announce that Brazil’s President Luiz Inácio Lula da Silva will speak at the inaugural Latin America FII PRIORITY Summit in Rio de Janeiro on 12 June, marking a significant milestone for the summit. RIO DE JANEIRO, June 11, 2024 (GLOBE NEWSWIRE) — FII Institute […]

FII PRIORITY Rio Press Release Image
FII Institute is honoured to announce that Brazil’s President Luiz Inácio Lula da Silva will speak at the inaugural Latin America FII PRIORITY Summit in Rio de Janeiro on 12 June, marking a significant milestone for the summit.

RIO DE JANEIRO, June 11, 2024 (GLOBE NEWSWIRE) — FII Institute is honoured to announce that Brazil’s President Luiz Inácio Lula da Silva will speak at the inaugural Latin America FII PRIORITY Summit in Rio de Janeiro on 12 June, marking a significant milestone for the summit.

President Lula, who will be joined by several high-ranking Brazilian and Latin American government officials, underscores the importance of FII PRIORITY Rio in addressing key global priorities and promoting investment opportunities. His attendance is a testament to Brazil’s integral role in shaping the future of global investment and sustainability.

“We are deeply honoured by President Lula’s decision to join us,” said Richard Attias, CEO of FII Institute. “As a global leader, his leadership and vision will greatly enrich our discussions and initiatives. The theme of our summit, ‘Invest in Dignity,’ was inspired by President Lula’s vision.”

The FII PRIORITY Rio de Janeiro Summit will take place at the Copacabana Palace from 11 to 13 June 2024, featuring a rich and diverse programme with world-renowned leaders and critical discussions on global issues.

For more information, please visit: https://fii-institute.org/Program-Rio. For media enquiries, please email: media@fii-institute.org and fii-institute@fsb.com.br.

About FII Institute
The Future Investment Initiative (FII) Institute is a global non-profit foundation driven by data with an investment arm focused on impactful initiatives for humanity. Through its PRIORITY Summits, the institute brings together leading minds to foster innovation and sustainable solutions across the globe.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b35d9202-dd4a-42c5-8e66-d4bd1dcf5749

GlobeNewswire Distribution ID 1000965653

Quantexa Debuts Q Assist, New Context Aware Generative AI Technology Suite

New AI advancements are helping industry leaders get data ready for AI and make impact Q Assist, New Context Aware Generative AI Technology Suite from Quantexa Q Assist, a context aware generative AI technology suite to help organizations augment trusted decision-making across teams of front-line and information workers HSBC is among several industry leaders participating […]

New AI advancements are helping industry leaders get data ready for AI and make impact

Q Assist, New Context Aware Generative AI Technology Suite from Quantexa
Q Assist, a context aware generative AI technology suite to help organizations augment trusted decision-making across teams of front-line and information workers
  • HSBC is among several industry leaders participating in Quantexa’s Lighthouse Program for early adopters
  • HSBC anticipates that streamlining of analysis and acceleration of processes could lead to significant productivity gains within the first year of deployment
  • Q Assist combines Quantexa’s Decision Intelligence Platform and Generative AI to augment decisions for sales, customer service, and compliance teams in financial services, TMT, and government agencies

LONDON, June 10, 2024 (GLOBE NEWSWIRE) — This Monday, on the Centre Stage at London Tech Week 2024Quantexa, the global leader in Decision Intelligence (DI) solutions for the public and private sectors debuted Q Assist, a context aware generative AI technology suite to help organizations augment trusted decision-making across teams of frontline and information workers. The announcement demonstrates progress against the company’s platform innovation roadmap and comes nearly a year after Quantexa detailed a significant investment in the global artificial intelligence (AI) industry and previewed Q Assist as a stand-alone LLM agnostic copilot.

With the new Q Assist Technology Suite, Quantexa customers will be able to operationalize generative AI for transformational gains without significant investment in infrastructure, tooling, and additional skilled resources.

Frontline and information workers can leverage the power of copilots, linked data, Quantexa’s knowledge graph capability, and other Decision Intelligence Platform features to enhance the accuracy and reliability of generative AI models that interact with all data (structured and unstructured), context, and insight across their organization. Combining LLMs with the rich context within Quantexa’s Decision Intelligence Platform enables a better understanding of data, safely grounds responses, increases performance and trust, and ensures teams have the most accurate, up-to-date information in a single place.

Q Assist, a context aware generative AI technology suite to help organizations augment trusted decision-making across teams of front-line and information workersFind out what Q Assist is and how it works with Quantexa’s Decision Intelligence Platform.
View the full video

Helping Customers Succeed in the Era of AI
HSBC is one of the organizations currently participating in the Lighthouse Program for early adopters. Each organization in the program envisions using Q Assist in several ways, including:

  • Streamlining analysis, investigation, and reporting tasks for information and knowledge workers to achieve greater efficiency.
  • Reducing the reliance on data science and operations teams for ad-hoc data requests, giving them time to focus on more strategic tasks.
  • Empowering customer facing teams with access to enriched data and insights they need to increase revenue and enhance customer experiences.
  • Enabling teams across an organization to consistently make trusted decisions that are traceable and accelerate operational process improvement.

BNY Mellon is currently evaluating joining HSBC in Lighthouse effort. Quantexa worked with Lighthouse Program participants to project one-, three-, and five-year benefits from deploying Q Assist within their customer facing, data science, and investigative teams. It found an almost immediate productivity gain across three core areas: time saving and efficiency, new opportunity identification, and increased conversion rates.

HSBC anticipates that democratizing analytics and accelerating processes across these areas could lead to productivity gains within the first year of deployment. The company also expects to free up employee’s time, allowing them to refocus on other strategic tasks.

David Rice, Global Chief Operating Officer, Commercial Banking at HSBC, said: “This new solution has the potential to enhance the efficiency and accuracy of complex tasks such as anti-money laundering investigations and sales strategies by providing trusted data and contextual analytics. The introduction of contextual analytics and innovation will enable HSBC to concentrate our resources more productively and ultimately help our customers.”

Quantexa estimates that a tier one global financial institution with three levels of defense in financial crime and fraud compliance efforts, generating approximately 15k alerts a month, could realize significant efficiencies and cost savings by deploying the Q Assist Generative AI Technology Suite:

  • Over £17M in savings enabled annually by enhancing and automating investigating and reporting processes across financial crime and fraud.

Quantexa’s CTO, Jamie Hutton, said: “Quantexa’s engineering principle of shaping solutions to deliver maximum customer value has allowed our clients to play an integral role in helping to shape the product requirements for Q Assist. Through the company’s Lighthouse Program for early adopters, we have the benefit of working with industry leaders that provide valuable feedback throughout our roadmap process.”

Eric Hirschhorn, Chief Data Officer, BNY Mellon, said: “We are excited to see this continued innovation from Quantexa. Our multi-year collaboration has helped us to break down data silos and unify our data with unprecedented accuracy. The next phase in our innovation efforts will see us exploring the potential of enabling frontline workers across the bank to use Gen AI to act on the data insights confidently and reach new levels of efficiency in the process.”

How the New Q Assist Generative AI Technology Suite Works
Quantexa’s new generative AI technology suite will combine Quantexa’s Decision Intelligence Platform and Generative AI through a new data integration layer, prompt builder, and copilot that accelerates the ability of teams to make critical business decisions.

Q Assist delivers trusted, extensible AI anchored by Quantexa’s Decision Intelligence Platform. This lets non-technical teams benefit from Quantexa’s critical platform capabilities including a connected data foundation, graph analytics, modeling, and scoring to augment and automate decision making. The Q Assist Technology Suite is comprised of three components:

  • Q Assist Integration Layer: the nerve center of Q Assist. It is a framework of tools, connectors, and APIs designed to securely link Quantexa’s Decision Intelligence Platform with LLMs and conversational AI systems right out-of-the-box.
  • Q Assist Prompt Builder: an extensible prompt management and sharing capability that easily integrates with external prompt engineering tools and frameworks, such as Microsoft’s Azure Prompt Flow, Semantic Kernel or AutoGen, to put the power in the hands of administrators to define and control prompts and responses that are grounded in contextual data generated by Quantexa’s Decision Intelligence Platform.
  • Q Assist Copilot: allows users to query large and disparate data via a natural language interface, understand and summarize data, insights, and findings in real-time, and automate research, investigation, and reporting tasks.

Today, the company is making Q Assist Generative AI Technology Suite capabilities available to a limited set of customers, with wider public availability planned for early 2025.

To learn more about how Quantexa is helping organizations get their data ready for AI, or to download the Total Economic Impact™ of Quantexa’s Decision Intelligence Platform by Forrester and start measuring the ROI of Decision Intelligence investments, please visit https://www.quantexa.com/discover/ai/.

About Quantexa
Quantexa is a global AI, data and analytics software company pioneering Decision Intelligence to empower organizations to make trusted operational decisions with data in context. Using the latest advancements in AI, Quantexa’s Decision Intelligence platform helps organizations uncover hidden risk and new opportunities by unifying siloed data and turning it into the most trusted, reusable resource. It solves major challenges across data management, customer intelligence, KYC, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. An independently commissioned Forrester TEI study on Quantexa’s Decision Intelligence Platform found that customers saw a three-year 228% ROI. Founded in 2016, Quantexa now has more than 700 employees and thousands of platform users working with billions of transactions and data points across the world.

Media Enquiries
C: Stephanie Crisp, Fight or Flight
E: Quantexa@fightorflight.com
OR
C: Adam Jaffe, SVP of Corporate Marketing
T : +1 609 502 6889
E : adamjaffe@quantexa.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dc615273-9f23-4d50-b6ec-62d59146a0e7

GlobeNewswire Distribution ID 1000965413

Foreign Investors in SF Gateway Marriott (JF27) Project Obtain Conditional Green Card Approvals

WASHINGTON, June 07, 2024 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first large wave of individual I-526 and I-526E petition approvals for investors in its SF Gateway Marriott (JF27) project. An I-526/I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their immediate family members […]

WASHINGTON, June 07, 2024 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first large wave of individual I-526 and I-526E petition approvals for investors in its SF Gateway Marriott (JF27) project. An I-526/I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their immediate family members for conditional permanent residency in the United States.

EB5 Capital has raised foreign investor funds across approximately 40 EB-5 projects throughout the United States, including half a dozen hotel projects in California. The SF Gateway Marriott (JF27) project, also known as Gateway at Millbrae Station, is a $300 million mixed-use development containing 400 apartment units and 200,000 square feet of commercial space in Millbrae, California, a suburb of San Francisco in San Mateo County. EB5 Capital raised foreign capital from 60 investors, representing a variety of nationalities, to finance a portion of the capital stack for the Residence Inn-branded hotel component of the larger development. The project opened to the public in early 2023 and created over 800 jobs as a result of the investment.

“We are happy that over a dozen investors have recently been approved in this project as several of them filed their cases with USCIS before the outbreak of the Covid-19 pandemic in late 2019,” said Molly FitzGerald, Director of Investor Communications and Engagement at EB5 Capital. “Our clients have patiently waited for USCIS to adjudicate their cases and they can now move on to the next step in their immigration process.”

The SF Gateway Marriott (JF27) project has created more than the number of jobs required by the EB-5 program to support all the investors with the remainder of their immigration journey at the I-829 stage when they apply for permanent residency in the United States. Until then, EB5 Capital is looking forward to additional I-526/I-526E investor approvals soon and will continue to keep its clients informed on the operations of the hotel.

About EB5 Capital

EB5 Capital provides qualified foreign investors with opportunities to invest in job-creating commercial real estate projects under the United States Immigrant Investor Program (EB-5 Visa Program). Headquartered in Washington, DC, EB5 Capital’s distinguished track record and leadership in the industry has attracted investors from over 75 countries. As one of the oldest and most active Regional Center operators in the country, the firm has raised over $1 billion of foreign capital across approximately 40 EB-5 projects. 100% of our investors’ funds are protected by the Federal Deposit Insurance Corporation (FDIC) insurance prior to their deployment into our projects. Please visit www.eb5capital.com for more information.

Contact:
Katherine Willis
Director, Marketing & Communications
media@eb5capital.com

GlobeNewswire Distribution ID 9150665

e& leads as the Top Telecoms Employer Brand in Employer Brand Index 2024

Top Telecoms Employer Brand   e& leads as the Top Telecoms Employer Brand e& UAE is the Top Telecoms Employer Brand in Brand Finance rankings e& ranked 16th in the Top 20 employer brands across all categories in 16 countries Achievement reflects the broader reputation of UAE as a global talent hub LONDON, June 07, […]

Top Telecoms Employer Brand
e& leads as the Top Telecoms Employer Brand
  • e& UAE is the Top Telecoms Employer Brand in Brand Finance rankings
  • e& ranked 16th in the Top 20 employer brands across all categories in 16 countries
  • Achievement reflects the broader reputation of UAE as a global talent hub

LONDON, June 07, 2024 (GLOBE NEWSWIRE) — e&, the global technology group, attained the highest position in Brand Finance’s inaugural Employer Brand Report 2024 with its UAE entity ranking as the Top Global Telecoms Employer.

The group also secured the 16th spot among the Top 20 Employer Brands across measured employer brands across financial services, telco, media, and tech (TMT), oil, gas, and energy, professional services, retail, automotive, and fast-moving consumer goods (FMCG) in Africa, Asia, Europe, and the United States.

Ali Al Mansoori, Group Chief People Officer, e&, said: “This recognition as an employer of choice reflects the incredible dedication and passion of our people, who are our greatest assets. It also reaffirms our commitment to cultivating a unified company culture where every employee is empowered to think differently, experiment fearlessly, and innovate continuously. In today’s rapidly evolving landscape, having a talented workforce is more critical than ever.”

David Haigh, CEO of Brand Finance, said: “Middle Eastern telecom brands are increasingly overtaking their European and American counterparts as desirable places to work. This reflects the career opportunities and exciting technological developments created by consistent, high-quality investment in the Middle East.”

Leading the way in employer branding and talent development in UAE, the group scored highly across several considerations, including as a ‘prestigious brand,’ an ‘inspiring vision,’ ‘enjoyable and rewarding work,’ and a ‘well-managed and governed company.’ e&’s achievement reflects the broader reputation of the UAE as a global talent hub and the preferred destination for people seeking to shape a prosperous future.

“At e&, we are committed to equipping our team with the skills necessary to navigate and thrive in the digital age. Our vision is not just to keep pace with change, but to lead it. We are building a resilient, forward-thinking workforce capable of driving our company and our community towards greater heights. Our strategy includes comprehensive training programs, partnerships with educational institutions, and an environment that rewards creativity and bold thinking. We are dedicated to creating opportunities for professional growth and supporting our team as they develop the technological skills and mindset essential for the future,” added Al Mansoori.

The inaugural “Employer Brand Index” report showcases the world’s top brands with global and regional league tables. The research-driven study is the first of its kind, measuring internal and external perceptions of employer brands from 16 countries. The Index is derived from responses from an anonymous survey of the public across various industries conducted via independent online panels.

The Brand Finance 2024 Employer Brand Index follows the release in January of the global brand rankings in which e& UAE was rated the strongest telecom brand globally (AAA rating) and the strongest brand in the Middle East and Africa (MEA) across all categories.

Brand Finance is the world’s leading brand valuation consultancy. For more than 25 years, it has been bridging the gap between marketing and finance by evaluating the strength of brands and quantifying their financial value to help organisations of all kinds make strategic decisions. Every year, Brand Finance conducts more than 5,000 brand valuations, supported by original market research, and publishes over 100 reports that rank brands across all sectors and countries.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5ab3f4e1-ad68-4a1f-b513-0f6dd6ce45d1

Contact:
Nancy Sudheer
nsudheer@eand.com

GlobeNewswire Distribution ID1000965168